Pharmexa Loses Bid To Restore Broad Patent Claims
An appeal board of the European Patent Office has upheld a ruling to revoke the broad patent claims of Danish pharmaceutical giant Pharmexa A/S over a cancer treatment....To view the full article, register now.
Already a subscriber? Click here to view full article